NSCLC

Open Access
Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang and Zhihao Wu

Cancer Biology & Medicine January 2025, 22 (1) 48-66; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0459
You have access
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
Tobias Boch, Jens Köhler, Melanie Janning and Sonja Loges

Cancer Biology & Medicine November 2022, 19 (11) 1543-1564; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0540
You have access
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu

Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178
You have access
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen

Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130
You have access
The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei

Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
You have access
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun and Jie He

Cancer Biology & Medicine August 2020, 17 (3) 768-781; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0121
You have access
DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang and Nengming Lin

Cancer Biology & Medicine May 2020, 17 (2) 387-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0380
You have access
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding and Linghua Meng

Cancer Biology & Medicine February 2019, 16 (1) 66-83; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0361
You have access
Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
Ye Tian, Changyu Sun, Limeng Zhang and Yuan Pan

Cancer Biology & Medicine May 2018, 15 (2) 157-164; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0182
You have access
EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
Yang Chen, Youyou Wang, Lujun Zhao, Ping Wang, Jifeng Sun, Rudi Bao, Chenghai Li and Ningbo Liu

Cancer Biology & Medicine February 2018, 15 (1) 39-51; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0118

Main menu

User menu

Search

NSCLC

Pages

Navigate

More Information

For Authors

Journal Services